Why now
Robotic-assisted bronchoscopy is expanding as clinicians seek more precise routes to peripheral lung lesions. LumenGuides is developing NaviScope around an architecture designed to sense, interpret and adapt as anatomy changes during navigation.
Category momentum
$1.05B
Projected robotic-assisted bronchoscopy market by 2026.
14.8%
Projected CAGR from 2026 through 2036.
NaviScope combines fiber-optic sensing, robotics and AI-guided decision support to build a current understanding of instrument position and airway anatomy during the procedure. The physician remains in control while the platform is designed to support informed navigation as the map changes.
Accomplishments to date
A functional platform has been developed utilizing AI-based real-time guidance.
In-vivo work at Shamir Medical Center in September 2025 informed the program designed to navigate without requiring fluoroscopy during the navigation phase.
A US provisional patent has been filed covering sensing and robotics integration.
The company has raised $1M and received approval for a $1.5M IIA grant.
Roadmap
Israel
Advance the initial clinical program in Israel and use early learnings to refine the evidence-generation plan.
United States
Develop the Yale clinical program while progressing the work intended to support a future 510(k) submission.
Europe
Establish the technical, clinical and quality-system workstreams needed to pursue the European CE marking pathway.
LumenGuides is focused on building the clinical, technical and regulatory evidence required to bring NaviScope forward responsibly.